Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension

被引：0
|
作者：
Ahmed Elgebaly
Bassant Abdelazeim
Omar Mattar
Mohamed Gadelkarim
Rehab Salah
Ahmed Negida
机构：
[1] Al Azhar University,Faculty of Medicine
[2] Cairo University,Medical Research Society
[3] Cairo University,Kasr Al Ainy School of Medicine
[4] Alexandria University,Faculty of Medicine
[5] Medical Research Group of Egypt,Faculty of Medicine
[6] Benha University,Faculty of Medicine
[7] Zagazig University,Student Research Unit
[8] TICO-Zagazig University,undefined
来源：
Clinical Autonomic Research | 2016年 / 26卷
关键词：
Droxidopa; Orthostatic hypotension; Dizziness; Pure autonomic failure; Parkinson’s disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：171 / 180
页数：9
相关论文
共 50 条
  • [41] Ampreloxetine Versus Droxidopa in Neurogenic Orthostatic Hypotension: A Comparative Review
    Hoxhaj, Pranvera
    Shah, Shruti
    Arce, Veronica E. Muyolema
    Khan, Wajiha
    Sadeghzadegan, Amirali
    Singh, Saumya
    Collado, Gaudy F.
    Goyal, Abhishek
    Khawaja, Imran
    Botlaguduru, Deepti
    Razzaq, Waleed
    Abdin, Zain U.
    Gupta, Ishita
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [42] Real-world droxidopa or midodrine treatment persistence in patients with neurogenic orthostatic hypotension or orthostatic hypotension
    Kymes, Steven M.
    Sullivan, Christine
    Jackson, Kenneth
    Raj, Satish R.
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2020, 225
  • [43] Number-needed-to-treat analysis of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Francois, C.
    Rowse, G. J.
    Hauser, R. A.
    Hewitt, L. A.
    MOVEMENT DISORDERS, 2015, 30 : S86 - S86
  • [44] A Mixed Treatment Comparison of Droxidopa and Midodrine for the Treatment of Neurogenic Orthostatic Hypotension
    Chen, J. J.
    Han, Y.
    Tang, J.
    Dashtipour, K.
    MOVEMENT DISORDERS, 2017, 32 (09) : E5 - E6
  • [45] Droxidopa Persistence in Neurogenic Orthostatic Hypotension May Be Affected by Titration Approach
    Amjad, Fand
    Polenchar, Brett
    Favit, Antonella
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 4485 - 4490
  • [46] Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?
    Horacio Kaufmann
    Clinical Autonomic Research, 2017, 27 : 1 - 3
  • [47] Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension
    Raj, Satish R.
    Hewitt, Lawrence Arthur
    EUROPEAN HEART JOURNAL, 2019, 40 (01) : 69 - 70
  • [48] Droxidopa for the treatment of neurogenic orthostatic hypotension and other symptoms of neurodegenerative disorders
    Perez-Lloret, Santiago
    Rey, Maria Veronica
    Pavy-Le Traon, Anne
    Rascol, Olivier
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (05): : 509 - 522
  • [49] A MIXED TREATMENT COMPARISON OF DROXIDOPA AND MIDODRINE FOR THE TREATMENT OF NEUROGENIC ORTHOSTATIC HYPOTENSION
    Joe, Y.
    Joe, W.
    Chen, J. J.
    VALUE IN HEALTH, 2017, 20 (05) : A189 - A189
  • [50] Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?
    Kaufmann, Horacio
    CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S1 - S3
12345